Sygnature Discovery has appointed Fraser McIntosh as Vice President, In Vivo Pharmacology. Fraser will lead the company’s in vivo drug discovery operations worldwide. Fraser brings 30 years of experience as a senior leader in drug discovery spanning the pharmaceutical, biotechnology, and contract research organization sectors. He has supported numerous programs into clinical development and fostered cross-functional collaboration across diverse therapeutic areas and drug modalities. ...